X
Record #40097

A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer

Original paper date
Oct 25, 2019
Original DOI
10.1002/cpt.2171
Institution
School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China · Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, China · Shanghai Institute for Advanced Immunochemical Studies, Shanghai Tech University, Shanghai, China · International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China · Department of Laboratory Medicine, Guangdong No. 2 Provincial People's Hospital, Guangzhou, China · State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University, Guangzhou, China · Department of Structural Biology, Stanford University, Stanford, California, USA · MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(HSC) Medicine - Immunology(HSC) Medicine - Internal(HSC) Medicine - Oncology
Notes from Retraction Watch

Appears to be retract and replace. Initially published Oct 2019, withdrawn December 2019, published again July 2021 with notice of previous withdrawal (GS)

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
2
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.3 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse